Dr. O’Riordan is an expert regulatory professional with a broad range of experience encompassing microbiology R&D and scientific writing, with more than 18 peer reviewed publications. She has served in regulatory advisory and execution roles for X4 Pharmaceuticals, Finch Therapeutics Group and Parexel Consulting, among other small and mid-sized pharmaceutical companies where she has successfully shepherded NDA and MAA applications to market approval. Dr. O’Riordan is RAC certified. She received a doctorate in microbiology from University College Cork and postgraduate certificates in Pharmaceutical Quality Assurance and Regulatory Affairs, Regulations and Specifications for Pharmaceutical Development and Manufacturing from the Technological University of Dublin.
